Thinking of joining a study?

Register your interest

Become a volunteer?

NCT04383145 | RECRUITING | Vascular Aneurysm

A Study in Patients With Thoracoabdominal Aortic Aneurysm Treated With the E-nside TAAA Multibranch Stent Graft System
Sponsor:

JOTEC GmbH

Brief Summary:

The INNER-B post-market clinical follow-up study is undertaken to evaluate the prevention of death related to a thoracoabdominal aneurysm when treated by the E-nside TAAA Multibranch Stent Graft System. The secondary objective is to evaluate the safety and clinical performance of the device.

Condition or disease

Vascular Aneurysm

Intervention/treatment

endovascular repair

Detailed Description:

In this study patients will be observed, who receive an E-nside TAAA Multibranch Stent Graft System for the endovascular treatment of a degenerative, atherosclerotic thoracoabdominal aortic aneurysm. The E-nside TAAA Multibranch Stent Graft will be implanted at the discretion of the treating physician. Participating physicians will be asked to provide their observations collected during routine care for patients he/she had decided to treat with the E-nside TAAA Multibranch Stent Graft System. Informed consent of the patients to allow the use of their clinical records for the purpose of this observational study will be obtained before data are being collected. The period of data collection will be approximately 60 months from the index procedure for each patient. Source document verification will be performed on 100% of patients; data from all visits will be reviewed and verified against existing source documents. Complete DICOM image files of the CT scans will be sent to the CoreLab for independent evaluation.

Study Type : OBSERVATIONAL
Estimated Enrollment : 150 participants
Official Title : INNER-B - A Post-market Clinical Follow-up Study in Patients With Thoracoabdominal Aortic Aneurysms Treated With E-nside TAAA Multibranch Stent Graft System
Actual Study Start Date : 2020-07-15
Estimated Primary Completion Date : 2024-09-01
Estimated Study Completion Date : 2030-02-28

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 85 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patient is between 18 and 85 years old
  • * Patient has a degenerative, atherosclerotic thoracoabdominal aortic aneurysm
  • * Patient has adequate iliac/femoral access compatible with an 8.5 mm OD delivery system
  • * Patient's aorta has no distinct angulation in the thoracovisceral segment of the aorta ranging from 40 mm proximal to the celiac trunk to 20 mm distal to the lowest renal artery
  • * All target branch vessels are suitable for antegrade cannulation
  • * Diameter of the landing zone in each branch vessel to be treated is ≥ 5 mm
  • * Length of landing zone in each branch vessel to be treated is ≥ 15 mm (preferably ≥ 20 mm)
  • * Patient must be available for the appropriate follow-up times for the duration of the study
  • * Patient has signed the informed consent before implantation of the E-nside Stent Graft
Exclusion Criteria
  • * Patient has allergies to materials necessary for endovascular repair (e.g. contrast media, anticoagulants or heparin, nitinol, polyester, gold, platinum-iridium)
  • * Patient has systemic infection or suspected systemic infection
  • * Patient has an infectious aneurysm
  • * Patient has an inflammatory aneurysm
  • * Patient has a ruptured aneurysm
  • * Patient has a traumatic aneurysm
  • * Patient has a symptomatic aneurysm
  • * Patient has an aortic dissection
  • * Patient has a congenital degenerative collagen disease or connective tissue disorder
  • * Diameter of ostium of branch vessel to be treated \< 4 mm
  • * Patient has thrombocytopenia (platelet count \< 150000/µl)
  • * Patient has an eGFR \< 30 ml/min/1.73m2 before the enrolment
  • * Patient has untreated hyperthyroidism
  • * Patient has a malignancy (progressive, stable or partial remission) with less than one-year projected survival
  • * Patient had a myocardial infarction or cerebrovascular accident \< 3 months ago
  • * Patient is planned to be treated with a chimney in the left subclavian artery
  • * Patient has had a previous surgical repair of descending thoracic aorta
  • * Patient will be treated or had been treated with a Nellix (Endologix) or Ovation (Endologix) or Altura (Lombard Medical) or Anaconda (Vascutek) stent graft
  • * Patient is enrolled or plans to be enrolled in another clinical study
  • * Patient is pregnant or breastfeeding or planning to become pregnant during the course of the study.
  • * Patient has a life expectancy of less than 3 years
A Study in Patients With Thoracoabdominal Aortic Aneurysm Treated With the E-nside TAAA Multibranch Stent Graft System

Location Details

NCT04383145

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

Germany,

Heidelberg University Hospital

Heidelberg, Germany, 69120